Zinc benefits: what the human trials found, condition by condition

Colds and respiratory infection

Zinc's best-known claim has a real but narrow basis. A 2013 Cochrane review of 16 treatment trials (1,387 people) found that zinc started within 24 hours of a cold shortened it by about a day on average. It did not make symptoms feel milder, and the trials disagreed with each other a great deal (I² of 89%).

The dose matters. The benefit appeared at lozenge doses of 75 mg/day or more, and nausea and bad taste were more common than with placebo. A 2017 analysis of seven lozenge trials found colds about a third shorter with zinc acetate or gluconate at 80 to 207 mg/day. Trials at the top of that range did no better than those at the bottom.

Prevention is a different story. The 2013 review included only two prevention trials, too few for the authors to recommend zinc for avoiding colds. For COVID-19, a 2021 randomized trial in 214 outpatients tested zinc gluconate at 50 mg/day, alone or with vitamin C. Symptom duration was not significantly shorter than with usual care, and the trial was stopped early. No trial isolating lab-confirmed influenza turned up.

Strength of evidence: moderate for shortening a cold with high-dose lozenges, limited by inconsistency. Negative for COVID-19 in the one trial available. Unproven for prevention. For more on zinc generally, see our zinc topic page.

Childhood diarrhea

This is the setting where zinc's evidence is broadest. A 2016 Cochrane review pooled 33 trials in 10,841 children. In children older than six months, oral zinc shortened diarrhea by about half a day, and the effect was larger, about a day, in children showing signs of malnutrition.

The limits are specific. Most trials ran in places with a high risk of zinc deficiency. Infants under six months saw no benefit, and vomiting was more common with zinc than placebo. The finding does not transfer neatly to well-nourished adults with a stomach bug, and no human trial supports zinc as a parasite treatment or a "cleanse."

Acne and other skin conditions

A 2020 systematic review of 22 trials of oral zinc found a benefit in 10 of 14 acne studies and in all three hidradenitis suppurativa studies. Results were weaker elsewhere: one of two eczema trials found a benefit, and the single psoriasis trial and single rosacea trial found none.

A separate 2020 meta-analysis found people with acne had lower serum zinc than people without it. Zinc, alone or as an add-on, was linked to significantly lower inflammatory papule counts, without more side effects than comparators. That analysis did not report doses or route in detail, which limits how precisely it can be applied.

Strength of evidence: modest and fairly consistent for acne, preliminary for hidradenitis, mixed for eczema, absent for psoriasis and rosacea. These were oral trials, not studies of zinc oxide creams.

Blood sugar, blood pressure and inflammation

Blood sugar. A 2019 meta-analysis of 32 randomized trials found fasting glucose 14.15 mg/dL lower and HbA1c 0.55 percentage points lower with zinc than with control. The effect was bigger in people who already had diabetes. An earlier 2013 analysis of 14 trials found a smaller overall fasting-glucose drop, about 0.19 mmol/L, and a larger one, about 0.49 mmol/L, in people with diabetes, metabolic syndrome or obesity. Doses and forms varied, and the trials used zinc alongside usual care, not instead of medication.

Blood pressure. A 2020 meta-analysis of nine trials found systolic pressure about 1.5 mmHg lower with zinc. Diastolic pressure did not change significantly, and there was no dose-response pattern. That is a small population average, not something an individual can count on.

Inflammation markers. A 2021 meta-analysis of eight trials found CRP about 1.68 mg/L lower with zinc, with larger drops at 50 mg/day or more and in people with kidney dysfunction. Lower-quality studies reported bigger effects, a warning sign. A second 2021 analysis of 21 trials (1,321 adults) also found lower CRP, TNF-alpha and an oxidative-stress marker, but with very high heterogeneity. Both measured blood markers, not symptoms or disease.

Depression, anxiety and ADHD

Depression. The evidence contradicts itself. A 2012 review found only four randomized trials, with scores improving most when zinc was added to antidepressants. A 2022 meta-analysis found lower depressive scores when zinc was given alone, the opposite pattern. Its cohort data linked the highest zinc intake to a 28% lower relative risk of a depression diagnosis, which is an association and not proof of prevention.

Anxiety. No trial tested zinc in people with an anxiety disorder. A 2025 meta-analysis of five trials in young women with premenstrual syndrome found a lower anxiety subscore with zinc, among other symptoms. A small 2023 trial in people on methadone maintenance found lower anxiety, depression and stress scores with about 12 mg/day of zinc for three months. Both populations are narrow.

ADHD. A 2022 meta-analysis of six trials in 489 children already diagnosed with ADHD found a small improvement in total symptom scores (Hedges' g about -0.62, with a confidence interval that barely excluded zero). Hyperactivity and inattention scores, measured separately, did not differ significantly. Certainty was low to moderate, and no dose-response relationship emerged.

Sleep

The sleep trials are small and heterogeneous. A 2011 trial in 43 elderly nursing-home residents with insomnia found better sleep quality over eight weeks, but the supplement combined melatonin, magnesium and 11.25 mg of zinc, so zinc's own contribution is unknown.

A 2018 trial in ICU night-shift nurses found better sleep-quality scores with 220 mg zinc sulfate (roughly 50 mg elemental) every 72 hours for a month. In a 2020 trial of young women with PMS, 30 mg/day for 12 weeks improved physical quality of life, but the sleep change was marginal and not statistically significant. A 2022 review of 31 sleep-supplement trials found too little comparable zinc data to pool. Evidence strength: weak.

Weight, testosterone and hair

Weight. Zinc is not a weight-loss aid. The largest meta-analysis, 41 randomized trials, found no significant effect on BMI or fat mass and a small average increase in body weight, about 0.68 kg. An earlier analysis of 27 trials saw a small loss in overweight adults that disappeared once trial duration was accounted for.

Testosterone. A small 1996 study found that restricting dietary zinc lowered testosterone in four young men. In nine elderly men who were marginally zinc-deficient, about 30 mg/day of elemental zinc for three to six months raised it. Nothing here shows a benefit in men with normal zinc status.

Hair. A 2019 review called zinc's role in hair loss biologically plausible but the evidence too limited to confirm. The most concrete example is a 1981 case report of one child with malabsorption-related deficiency whose hair and nails improved on clinician-prescribed 40 mg/day. A 2015 review also found that a standard blood zinc test has poor sensitivity and specificity alone, so deficiency is a clinical diagnosis, not a symptom guess.

Safety, absorption and how the evidence compares

Several trial doses sit above the 40 mg/day adult upper limit for ongoing use. Sustained high intake can lower copper status. In a 1984 trial, 50 mg/day for six weeks reduced a copper-dependent enzyme's activity in healthy men before plasma copper changed. A 2008 case series linked heavy long-term use of zinc-containing denture cream to copper deficiency and neurologic disease. Zinc gluconate placed inside the nose was tied to severe, sometimes permanent loss of smell in a 2004 case series. Details on limits are in how much zinc is too much.

Absorption can shift results. A controlled study found calcium, including a single 600 mg carbonate dose with a meal, reduced zinc absorption. Nonheme iron supplements did too, increasingly as the iron-to-zinc ratio rose, while heme iron and iron eaten with zinc in food did not. Quinolone antibiotics bind zinc in the gut and are absorbed less well when taken together.

Form matters somewhat. At a 10 mg dose without food, zinc citrate and gluconate were absorbed about equally and both beat zinc oxide. A small tracer study found gluconate absorbed better than sulfate. Bisglycinate's bioavailability was 43.4% higher than gluconate's in 12 women after one dose. A review favoring glycinate and gluconate came from a manufacturer's science team, so weigh it accordingly. See zinc forms compared.